Transgenic chickens used to manufacture proteins
Researchers at the Roslin BioCentre in Scotland have advanced a program to use transgenic chickens to create new drugs for a variety of ailments. By injecting genes for certain proteins into the hen's gene for ovalbumin, a protein that makes up more than half of egg whites, the chickens produced those therapeutic proteins in their egg whites. A new generation of transgenic therapies are in the pipeline, many using goats to create a new way to manufacture meds in their milk. Backers say that using farm animals to develop drugs would be much less expensive than current manufacturing methods.
"With the demand for therapeutic protein drugs increasing, the efficient generation of transgenic hens that produce functional protein drugs at high levels in egg whites marks an important step in the development of this technology," according to a statement released by the Proceedings of the Proceedings of the National Academies of Science, which published the research in its online edition.
- read the report on the chicken research from Xinhuanet
Related Articles:
GTC inks new transgenics collaboration deal. Report
EMEA rejects GTC's therapy from modified goats. Report
Pharming gets orphan status for transgenic therapy. Report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


